Name: Proposals Due: RNCP-Wide Dosimetry Guidance and Monitoring of Sources and Irradiation Protocols
Start: 2019-07-19T00:00:00-04:00
End: 2019-07-19T23:59:59-04:00
Location: Global Biodefense Calendar

More on pathogens and preparedness

US Invests Additional 44 Million in Smallpox Vaccine Manufacturing

by Global Biodefense January 22, 2019, 3:26 am
Newsletter

Pathogens + Preparedness News

First Name

Last Name

Organization Type

Email address:

Subscribe to Global Biodefense
New Vaccine Manufacturing Innovation Centre Bolsters UK Pandemic Preparedness

by Global Biodefense January 22, 2019, 3:00 am
BARDA Looks to Expand Clinical Studies Network for Biodefense Countermeasures
Ridgeback Biotherapeutics Licenses mAb114 Ebola Treatment from NIAID

by Global Biodefense December 13, 2018, 2:22 pm
Whooping Cough: Tulane Awarded $8.5M to Develop Next-Generation Pertussis Vaccine

by Global Biodefense November 15, 2018, 10:57 am
Two Vaccines Against H7N9 Influenza Viruses Show Safety and Immunogenicity in Ferrets

by Global Biodefense November 11, 2018, 5:33 am
Most Know Kids Can Die From Flu, Yet Many Still Haven’t Had Children Vaccinated
Join Us at SMi’s Superbugs & Superdrugs Conference USA

by Global Biodefense November 8, 2018, 7:35 am
BARDA Searching for Director of DRIVe Program

by Global Biodefense November 7, 2018, 11:41 am
Antibiotic Resistance Could Take Us Back To the ‘Dark Ages’

by Global Biodefense November 6, 2018, 2:22 pm
Multidomain Antibody to Neutralize Flu Virus Through Entire Season
Seizure Drug Approval Expands Countermeasures for Chemical Weapons Attack

by Global Biodefense October 31, 2018, 10:43 am

Congratulations. You've reached the end of the internet.

Medical Countermeasures

More on pathogens and preparedness

US Invests Additional 44 Million in Smallpox Vaccine Manufacturing

New Vaccine Manufacturing Innovation Centre Bolsters UK Pandemic Preparedness

BARDA Looks to Expand Clinical Studies Network for Biodefense Countermeasures

Ridgeback Biotherapeutics Licenses mAb114 Ebola Treatment from NIAID

Whooping Cough: Tulane Awarded $8.5M to Develop Next-Generation Pertussis Vaccine

Two Vaccines Against H7N9 Influenza Viruses Show Safety and Immunogenicity in Ferrets

Most Know Kids Can Die From Flu, Yet Many Still Haven’t Had Children Vaccinated

Join Us at SMi’s Superbugs & Superdrugs Conference USA

BARDA Searching for Director of DRIVe Program

Antibiotic Resistance Could Take Us Back To the ‘Dark Ages’

Multidomain Antibody to Neutralize Flu Virus Through Entire Season

Seizure Drug Approval Expands Countermeasures for Chemical Weapons Attack

In Fight Against Superbugs, BARDA Looks to Shore Up National Stockpile Countermeasures

Army Researchers Explore Protective Filtration Benefits of Biologically-Templated Carbon Nanofiber (BioCNF)

Turns Out, Bat Influenza Can Give You the Flu

Implications of Emerging Microfluidics Technology for Chemical, Biological, and Nuclear Weapons

Nanofibers in Face Masks And Respirators to Provide Better Protection